Evidence map›Paper›PMID 28244800›Full record

ArticleAnnals of the American Thoracic Society2017

Reduced Forced Vital Capacity in an African Population. Prevalence and Risk Factors.

Daniel O Obaseki, Gregory E Erhabor, Olayemi F Awopeju, Olufemi O Adewole, Bamidele O Adeniyi, Emerita A Sonia Buist, Peter G Burney

Open access · greenAbstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Observational
  3. Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Daniel O Obaseki1 Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.ORCID http://orcid.org/0000-0003-3798-7526
Gregory E Erhabor1 Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.
Olayemi F Awopeju1 Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.
Olufemi O Adewole1 Department of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.
Bamidele O Adeniyi2 Department of Medicine, Federal Medical Centre, Owo, Nigeria.
Emerita A Sonia Buist3 Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon; and.
Peter G Burney4 Respiratory Epidemiology and Public Health, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Obafemi Awolowo University · NGFederal Medical Centre · NGImperial College London · GBOregon Health & Science University · US

Funding

Wellcome Trust 089405
6 · The paper itself

Abstract

rationaleBlack Africans have reduced FVC compared with white persons, but the prevalence and determinants of reduced values are not well understood.

objectivesTo evaluate the prevalence and factors leading to reduced FVC in a Nigerian population and to examine current theories regarding the determinants of this difference.

methodsWe studied the ventilatory function of 883 adults aged 40 years or older participating in the Burden of Obstructive Lung Disease Study in Ile-Ife, Nigeria. Respondents completed pre- and post-bronchodilator spirometry test and provided information on their smoking history, respiratory symptoms, risk factors, and diagnoses, including anthropometric details. We used standard categories to define body mass index as either underweight, normal, overweight, or obese. We defined reduced FVC as a post-bronchodilator FVC below the lower limit of normal using National Health and Nutrition Examination Survey (NHANES) equations, Global Lung Function Initiative 2012 equations, and local reference equations based on nonsmoking study participants without a respiratory diagnosis. We fit multivariate linear regression models to FVC as a continuous measure, adjusting for age, sex, height, and other confounders.

resultsThe prevalence of reduced FVC was 70.4% for men and 72.8% for women when using NHANES values for white Americans, 17.8% for men and 14.4% for women using NHANES equations for African Americans, and 15.5% for men and 20.5% for women using the Global Lung Function Initiative 2012 equations. Using the equations derived from nonsmoking respondents in the survey without a respiratory diagnosis, the prevalence of reduced FVC was less than 4% for both men and women. FVC was lower in participants who had less than 7 years of education (FVC, -96 ml; 95% confidence interval [CI], -172 to -19), were underweight (FVC, -269 ml; 95% CI, -464 to -73), were overweight (FVC, -132 ml; 95% CI, -219 to -46), and were obese (FVC, -222 ml; 95% CI, -332 to -112).

conclusionsThere is a wide variation in the prevalence of reduced FVC based on the reference standard used. This variation is not satisfactorily explained by factors thought to affect FVC within individual populations. However, the prevalence strongly associates with both education level and body mass index in this population, regardless of the specific standard used.

Indexed as

Vital CapacityAdultAgedAge FactorsBlack or African AmericanBlack PeopleFemaleHumansLinear ModelsLungMaleMiddle AgedMultivariate AnalysisNigeriaNutrition SurveysPrevalenceFVClung functionNigeriaspirometry

Identifiers

PMID28244800
PMCPMC5427737
OpenAlexW2593574693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.